查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829645

2025年全球先天性心臟疾病設備市場報告

Congenital Heart Defect Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，先天性心臟疾病器材市場呈現強勁成長勢頭，市場規模從2024年的29.1億美元成長至2025年的31.1億美元，複合年成長率達6.8%。預測期內的成長歸因於醫療保健意識宣傳活動的不斷提升、心臟缺陷篩檢計畫的不斷推進、醫療設備法規的不斷改進、先天性心臟病盛行率的不斷上升以及器官衰竭風險的不斷上升。

預計未來幾年先天性心臟疾病器材市場規模將強勁成長，到2029年將達到41.4億美元，複合年成長率為7.4%。預測期內的成長可歸因於臨床試驗的增加、老年人口的快速成長、先天性心臟疾病率的上升、政府支持和資金的增加以及專科醫療中心的增加。預測期內的主要趨勢包括技術進步、數位健康科技、個人化醫療、3D列印技術和穿戴式裝置。

先天性心臟疾病裝置是專門設計用於治療和管理先天性心臟缺陷的醫療器材或植入。這些裝置用於診斷、治療和支持先天性心臟疾病患者的心臟功能，旨在恢復正常血流並改善心臟功能。

先天性心臟疾病裝置的主要類型包括導管、心律調節器（單腔、雙腔、雙心室和無線）、植入式心臟整流去顫器、雙心室裝置和植入式心電圖記錄器。導管是插入體內的細而柔韌的管子，用於診斷、治療和監測等各種目的。這些裝置用於治療各種類型的先天性缺陷，例如室間隔缺損、房室間隔缺損、三尖瓣閉鎖和開放性動脈導管。它們廣泛應用於醫院、專科診所、學術研究機構和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，心臟疾病系列提供先天性心臟疾病器材市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的先天性心臟疾病心臟疾病細分市場、市場趨勢和機遇，以及您在先天性心臟疾病器行業取得成功所需的數據。本先天性心臟疾病器械市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年7.4%的成長率預測，較我們先前對該市場的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致兒科封堵器和可生物分解的鼻中隔修補片的供應鏈中斷，這些產品主要來自法國和瑞典等主要地區，從而可能導致兒科心臟介入治療的延誤和先天性疾病手術費用的增加。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

預計先天性心臟疾病器械市場的成長將受到微創手術的推動。這些手術涉及使用專門的工具和技術透過小切口或自然身體孔口進行手術，以最大限度地減少創傷並改善恢復。推動微創手術興起的因素包括技術進步、患者對微創治療方法的偏好、手術技術的改進以及減少恢復時間和併發症的好處。先天性心臟疾病器械在這些手術中發揮關鍵作用，透過更小的切口和基於導管的方法來實現心臟異常的診斷、治療和管理。例如，根據美國整形外科醫師協會 (ASPS) 的數據，2022 年美國進行了 23,672,269 例微創美容手術，比前一年增加了 7%。微創手術的增加反過來又推動了先天性心臟疾病器械市場的發展。

先天性心臟疾病器械市場包括室間隔阻塞設備、心臟瓣膜、開放性動脈導管(PDA) 器械和生物假體器械的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球先天性心臟疾病設備：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球先天性心臟疾病設備市場：成長率分析
  • 全球先天性心臟疾病設備市場表現：規模與成長，2019-2024
  • 全球先天性心臟疾病設備市場預測：規模與成長，2024-2029，2034
  • 全球先天性心臟疾病設備：總目標市場（TAM）

第6章 市場細分

  • 全球先天性心臟疾病設備市場（按設備類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 導管
  • 心律調節器
  • 單室調節器
  • 雙腔心律調節器
  • 雙心室節律器
  • 無導線心律調節器
  • 置入式除顫器
  • 雙心室裝置
  • 植入式心電圖循環記錄儀
  • 其他設備類型
  • 全球先天性心臟疾病設備市場（按缺陷類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 心房中膈缺損症
  • 室間隔缺損
  • 房室間隔缺損
  • 三尖瓣閉鎖
  • 動脈幹
  • 其他缺陷類型
  • 全球先天性心臟疾病設備市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 學術研究機構
  • 其他最終用戶
  • 全球先天性心臟疾病設備市場：按導管類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 球囊導管
  • 診斷導管
  • 引導管
  • 全球先天性心臟疾病設備市場：按心律調節器類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 單室調節器
  • 雙腔心律調節器
  • 雙心室節律器
  • 無導線心律調節器
  • 全球先天性心臟疾病設備市場：置入式除顫器市場（按類型）、業績及預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔ICD
  • 雙腔ICD
  • 皮下植入式心臟復律去顫器
  • 全球先天性心臟疾病設備市場：雙心室設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • Crt-P（心臟再同步治療心律調節器）
  • Crt-D（心臟再同步治療去心房顫動）
  • 全球先天性心臟疾病設備市場：細分：植入式心電圖環路記錄器（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 傳統嵌入式循環錄音機
  • 皮下植入式循環記錄儀
  • 全球先天性心臟疾病設備市場：依其他設備類型細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 經導管心臟瓣膜
  • 心室輔助裝置（VADS）

第7章 區域和國家分析

  • 全球先天性心臟疾病設備市場（按地區、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 全球先天性心臟疾病設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 先天性心臟疾病設備市場：競爭格局
  • 先天性心臟疾病設備市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Medtronic plc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • WL Gore & Associates Inc.
  • Masimo Corporation
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • MicroPort Scientific Corporation
  • Stereotaxis Inc.
  • Berlin Heart GmbH
  • Ventracor Limited
  • Syncardia Systems LLC
  • On-X Life Technologies Inc.
  • Occlutech Holding AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Response Biomedical Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年先天性心臟疾病器材：提供新機會的國家
  • 2029年先天性心臟疾病設備市場：細分市場帶來新機會
  • 2029年先天性心臟疾病設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29862u

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.91 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.14 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The forecast of 7.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for pediatric-sized occluders and biodegradable septal repair patches, sourced from key regions such as France and Sweden, which could lead to delayed pediatric cardiac interventions and increased surgical expenses for congenital conditions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Subsegments:
  • 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
  • 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
  • 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
  • 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
  • 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca plc.; Abbott Laboratories; GlaxoSmithKline plc.; Medtronic plc.; Philips Healthcare; Boston Scientific Corporation; W. L. Gore & Associates Inc.; Masimo Corporation; Lepu Medical Technology (Beijing) Co. Ltd.; MicroPort Scientific Corporation; Stereotaxis Inc.; Berlin Heart GmbH; Ventracor Limited; Syncardia Systems LLC; On-X Life Technologies Inc.; Occlutech Holding AG; Sahajanand Medical Technologies Pvt. Ltd.; Response Biomedical Corporation; Xeltis AG; Procyrion Inc.; Heartstitch Inc.; Cardia Inc.; OSYPKA Medical GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Congenital Heart Defect Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Congenital Heart Defect Devices Market Growth Rate Analysis
  • 5.4. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Congenital Heart Defect Devices Total Addressable Market (TAM)

6. Congenital Heart Defect Devices Market Segmentation

  • 6.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheters
  • Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • Implantable Cardioverter Defibrillators
  • Biventricular Devices
  • Implanted Cardiac Loop Recorders
  • Other Device Types
  • 6.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect
  • Ventricular Septal Defect
  • Atrioventricular Septal Defect
  • Tricuspid Atresia
  • Truncus Arteriosus
  • Other Defect Types
  • 6.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Academic And Research Institute
  • Other End Users
  • 6.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Catheters
  • Diagnostic Catheters
  • Guiding Catheters
  • 6.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • 6.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Icds
  • Dual-Chamber Icds
  • Subcutaneous Icds
  • 6.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crt-P (Cardiac Resynchronization Therapy Pacemakers)
  • Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 6.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Implantable Loop Recorders
  • Subcutaneous Implantable Loop Recorders
  • 6.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Ventricular Assist Devices (VADS)

7. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 7.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Defect Devices Market

  • 8.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Defect Devices Market

  • 9.1. China Congenital Heart Defect Devices Market Overview
  • 9.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Defect Devices Market

  • 10.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Defect Devices Market

  • 11.1. Japan Congenital Heart Defect Devices Market Overview
  • 11.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Defect Devices Market

  • 12.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Defect Devices Market

  • 13.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Defect Devices Market

  • 14.1. South Korea Congenital Heart Defect Devices Market Overview
  • 14.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Defect Devices Market

  • 15.1. Western Europe Congenital Heart Defect Devices Market Overview
  • 15.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Defect Devices Market

  • 16.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Defect Devices Market

  • 17.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Defect Devices Market

  • 18.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Defect Devices Market

  • 19.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Defect Devices Market

  • 20.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Defect Devices Market

  • 21.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • 21.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Defect Devices Market

  • 22.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Defect Devices Market

  • 23.1. North America Congenital Heart Defect Devices Market Overview
  • 23.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Defect Devices Market

  • 24.1. USA Congenital Heart Defect Devices Market Overview
  • 24.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Defect Devices Market

  • 25.1. Canada Congenital Heart Defect Devices Market Overview
  • 25.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Defect Devices Market

  • 26.1. South America Congenital Heart Defect Devices Market Overview
  • 26.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Defect Devices Market

  • 27.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Defect Devices Market

  • 28.1. Middle East Congenital Heart Defect Devices Market Overview
  • 28.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Defect Devices Market

  • 29.1. Africa Congenital Heart Defect Devices Market Overview
  • 29.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 30.1. Congenital Heart Defect Devices Market Competitive Landscape
  • 30.2. Congenital Heart Defect Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc.
  • 31.2. Philips Healthcare
  • 31.3. Boston Scientific Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Masimo Corporation
  • 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Stereotaxis Inc.
  • 31.9. Berlin Heart GmbH
  • 31.10. Ventracor Limited
  • 31.11. Syncardia Systems LLC
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Occlutech Holding AG
  • 31.14. Sahajanand Medical Technologies Pvt. Ltd.
  • 31.15. Response Biomedical Corporation

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

34. Recent Developments In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Congenital Heart Defect Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Congenital Heart Defect Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Congenital Heart Defect Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer